Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

Products > On-Demand Supplier Webinar

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?

Published: 26-Jan-2017 | Format: Webinar | Document type: Supplier Webinar

The FDA recently authorized a level C qualified health claim for high-amylose maize resistant starch and a reduced risk of type 2 diabetes. The CDC reports that 1 in 3 American adults have prediabetes and are at risk for developing type 2 diabetes1—with 60% of consumers interested in buying foods that help them “reduce the risk of type 2 diabetes”2. Learn about this qualified health claim, and find out how HI-MAIZE® resistant starch can help you create innovative products.

                    1 Click here for CDC reference

                    2 Ingredion proprietary consumer research


  • Maria Stewart, PhD

    Maria Stewart, PhD

    Clinical Research Lead, Global Nutrition R&D


  • Santiago Vega, MBA

    Santiago Vega, MBA

    Senior Marketing Manager, Nutrition North America